Shares of Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as $3.19 and last traded at $3.23, with a volume of 5491 shares trading hands. The stock had previously closed at $3.24.
Hypera Price Performance
The firm has a market cap of $2.05 billion, a PE ratio of 5.89 and a beta of 1.02. The business has a fifty day moving average price of $4.20 and a two-hundred day moving average price of $4.91.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Five stocks we like better than Hypera
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Netflix Is On Track To Hit $1,000 By Christmas
- With Risk Tolerance, One Size Does Not Fit All
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
